Colossal, values the Dallas-based startup at a staggering $10.2 billion. Besides making it the first startup founded in Texas ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Colossal Biosciences, the world’s first company dedicated to bringing back animals from extinction, has secured $200 million ...

The company said Jan. 15 that it has raised $200 million in series C funding led by TWG Global, the investment firm headed by ...

Editas Medicine (EDIT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Yanan Zhu ...

Elon Musk's SpaceX on Wednesday pushed back its latest orbital flight test of Starship, the colossal prototype rocket the ...

In Episode 746 of Power Athlete Radio, Dr. Adeel Khan dives into cutting-edge advancements in regenerative medicine, focusing on induced pluripotent stem cells ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends ...

Orna Therapeutics and Vertex will use lipid nanoparticle system to develop gene-editing therapies for people with SCD and TDT ...

Tune Therapeutics, an epigenome-editing company with origins at Duke University, has raised over $175 million in financing to advance a potential treatment for chronic hepatitis B and other diseases.

Lackawanna College will use a nearly $1 million grant to partner with a Hazleton-based biotechnology company to conduct hemp ...